Already in July, Anders Gersel Pedersen, Head of Research and Development in Lundbeck, informed the CEO about his retirementplans. The Danish drug group now initiated the search for a successor with rich international experience.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.